maskers..........I understand all too well your question of when are we going to be evaluated for CYGX "intellectual
property" which is why ISIS and GNTA are PPS higher than CYGX.
Remember CYGX has the only patent on "ssDNA vector
delivery" - the only one ! And the RNAi system of ISIS has only been successful in one eye drop Rx and has had numerous disappointments and failures. We are comparing apples with a rare delicious fruit very new to medicine. It's genetics but CYGX system appears to work to a degree we can't even compare.
(see some of the posts I have mentioned by Thalio which review the difference of the systems at work)
CYGX has not been recognized yet and has to get its PPS up to $4.00 and get a NASDAQ listing so we will get Institutional investment. Them CYGX will surpass the stocks you mentioned.
It's going to take a bit of time. Perhaps, no definitely - months?
Meanwhile we will get some very interesting NA's which you won't find with the stocks you have mentioned.
Nov. 11 Genetic workshop by Dr.Chen in San Diego should be interesting plus the reaction to it by the science community.
Don't forget, CYGX was a $.03 stock in the early 2003 summer with no funds (less than 6 mos. ago) - it has risen more than 1600% since then.
But I know what you mean........the wait, when we are sitting on top of something like this.
Rick
Market Data 
Markets 
AI
